Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Articles

12315 items
6:57 AM, Aug 31, 2018  |  BC Extra | Financial News

Qiming, Hillhouse lead Jacobio's $55M series C

Cancer company Beijing Jacobio Pharmaceutical Co. Ltd. (Beijing, China) raised $55 million in a series C round led by Qiming Venture Capital and Hillhouse Capital. Prudence Investment Management also participated. Jacobio's lead candidate JAB-3068, a small...
3:37 PM, Aug 30, 2018  |  BC Extra | Financial News

PureTech Founder Steinberg departs for Longwood Fund

In a tweet, David Steinberg said he will step down as chief innovation officer of science and technology development firm PureTech Health plc (LSE:PRTC), effective Sept. 10. He will join Longwood Fund, but did not...
12:59 PM, Aug 30, 2018  |  BC Extra | Financial News

Arvinas looking to raise $100M in IPO

Protein degradation company Arvinas LLC (New Haven, Conn.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, Citigroup and Piper Jaffray. Arvinas is developing small molecules based on its...
4:00 AM, Aug 30, 2018  |  BC Extra | Financial News

Sequoia China leads seed round for next-gen T cell therapy play

RootPath Inc. (Cambridge, Mass.) raised $7 million in a seed round led by Sequoia China. Fellow new investors Volcanics Venture, Baidu Ventures and Nest.Bio Ventures also participated. Co-founder and CEO Xi Chen told BioCentury the funding...
3:51 PM, Aug 29, 2018  |  BC Extra | Financial News

Sutro proposes $75M IPO

Sutro Biopharma Inc. (South San Francisco, Calif.) proposed on Wednesday to raise $75 million in an IPO on NASDAQ underwritten by Cowen, Piper Jaffray, JMP Securities and Wedbush PacGrow. Concurrent with the proposed IPO, Merck &...
10:15 AM, Aug 29, 2018  |  BC Extra | Financial News

Tempus raises $110M series E

Tempus Labs Inc. (Chicago, Ill.) raised $110 million in a series E round led by new investor Baillie Gifford and funds managed by T. Rowe Price. Existing investors Revolution Growth, New Enterprise Associates and other...
11:00 PM, Aug 28, 2018  |  BC Extra | Financial News

Longitude joins syndicate for women's health play KaNDy's £25M series C

KaNDy Therapeutics Ltd. (Stevenage, U.K.) raised £25 million ($31.9 million) in a series C round. New investor Longitude Capital joined existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed in the...
11:01 AM, Aug 28, 2018  |  BC Extra | Financial News

Akcea, Ionis tumble on volanesorsen setback

Akcea Therapeutics Inc. (NASDAQ:AKCA) and Ionis Pharmaceuticals Inc. (NASDAQ:IONS) each fell double-digits on Tuesday following a complete response letter from FDA for Waylivra volanesorsen. Akcea slid $8.39 (25%) to $24.73, while Ionis was down $8.53...
3:31 PM, Aug 27, 2018  |  BC Extra | Financial News

Harbour BioMed raises $85M on heels of cancer deals

Immuno-oncology company Harbour BioMed (Shanghai, China) raised $85 million in a series B round led by GIC. New investors China Life Private Equity Investment Company and Vertex Ventures also participated as did existing investors AdvanTech...
3:14 PM, Aug 24, 2018  |  BC Extra | Financial News

Y-mAbs aiming for $92M IPO

Y-mAbs Therapeutics Inc. (New York, N.Y.) filed to raise up to $92 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch, Cowen, Canaccord Genuity and BTIG. Y-mAbs hopes to submit BLAs next year for...

Pages